• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Stepping into the Spotlight for 2021

    The Independent Beauty Association Supports Sensible Reform

    Essential Workers

    A Clean Commitment

    Deliver & Delight
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    Mix:Bar Launches at Target

    Crystal Deodorant Unveils Magnesium-Enriched Sticks

    Euromonitor Reveals Top 10 Global Consumer Trends for 2021

    A Surge in Interest for Supplements & Vitamins

    Gattefossé Launches Inspiration Collection
    Blog
    Online Exclusives
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    HappiTV
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    3. Henkel

    12. Mary Kay

    2. L’Oréal

    4. Kao

    41. Spartan Chemical
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    A Surge in Interest for Supplements & Vitamins

    Honest, Refillable Cleaners

    Nailing It in 2020

    P&G, L'Oréal & Amorepacific Make News at CES

    PurposeBuilt Brands Files for IPO
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    Mix:Bar Launches at Target

    Crystal Deodorant Unveils Magnesium-Enriched Sticks

    Euromonitor Reveals Top 10 Global Consumer Trends for 2021

    A Surge in Interest for Supplements & Vitamins

    Gattefossé Launches Inspiration Collection
    Lab Equipment
    Mixing
    Packaging
    Testing

    Three Form Vertical Beauty Alliance

    Logo Design Trends for 2021 & Beyond

    Coming Clean About Stink

    Henkel Reaches Sustainable Packaging Milestone

    Ross Designs Mixer for Increased Shear
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Croda

    KLK OLEO

    QRS (Quality Resourcing Services)

    Ashland

    Sabinsa Cosmetics, a division of Sabinsa Corporation
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Experts Opinion
    • Slideshows
    • HappiTV
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Claims Substantiation

    Selecting the Population for Human Clinical Studies

    ...

    Selecting the Population for Human Clinical Studies
    Selecting the Population for Human Clinical Studies
    Related CONTENT
    • Isosorbide Di-(Linoleate/Oleate) Treats Xerotic Pruritic Skin
    • International Cosmetics Science Centre Founder Honored
    • Racial Bias in Retail
    • Follain Supports Black-Owned Beauty Businesses
    • The Next Normal
    Nava Dayan, Dr. Nava Dayan LLC03.01.18
    PART I
    Most of the clinical testing conducted for cosmetics and personal care products, either for safety or for efficacy, are interventional studies and not observational in nature. Interventional studies are designed to determine whether experimental treatments are safe and/or effective under controlled regimen and environment. Observational studies aim at analyzing specific issues in relatively large populations in a natural setting. This means that in an interventional setting, a selected population is put under specific regimen of treatment for a certain period of time and is observed and measured at pre-determined time intervals. Who are the people testing your products? What do they do in life? What are their dreams, their desires, their problems, their motivation? Why do they enroll to the study for your product? What do they know about your product? What do they know about your path to develop it? What do they know about you? And, most importantly, how can you frame and control their selection so the study objective is best served? These people are the foundation of your study. Without them and their commitment, the study cannot be performed.


    When you are sending your product to be tested by a clinical research organization (CRO) or have a study director appointed to conduct it in-house, you are connecting to a population of humans through a mediator. You are influencing their life for a purpose you believe is meaningful. How do you ensure that this selected panel is the most appropriate for your product? If you neglect or underestimate the selection of a precise panel, not only can your study results become meaningless and remote from your goal, but you in fact wasted your time resources as well as the panelists’. Understanding the required population characteristics, defining it and expressing it clearly in the protocol is one of the critical aspects in study design.


    Unlike in the pharmaceutical industry, for example, where the FDA sets guidelines to testing criteria for skin diseases such as acne, there are no specific detailed cosmetic and personal care guidelines for forming such criteria and they are to be customized for the study objective. Sometime, when relevant, selected criteria may be adopted from pharmaceutical guidelines. Outlining these principles should be a collaborative effort between marketing and R&D. Marketing professionals should frame the market population to which this product is created. A precise, detailed description allows more specific and accurate recruitment. Knowing the prevalence of such population in the geographical area of recruitment can further ease the process. If the prevalence is low, the criteria should be adjusted or a different facility that can recruit this population should be selected. For example, if the product is aimed at specific ethnicity and the clinical facility is located in an area at which such ethnicity is rare demographically, the recruitment of the desired panel may not be possible and a more appropriate CRO for the population should be considered. Research and development professionals should further add and refine the criteria based on clinical and scientific attributes.


    Exclusion/Inclusion


    The selection of an appropriate study population is a key in the overall study success. Many times the study sponsor counts on the CRO available pool of panelists, however, this population may not be ideal for the desired study and since the CRO is not aware of specific attributes of the product developed it should be carefully directed at the relevant study population to recruit.


    This criteria of defining the panelists to participate in the study is termed “exclusion/ inclusion” criteria and it is aimed at shaping the study to produce reliable results. The “exclusion criteria” are those that preclude a panelist to participate in the study. For example, if the product is targeted at demonstrating an effect on mild to moderately oily skin; the study director should consider excluding panelists with very oily skin and should set a baseline criteria for such by which “mild-moderate” can be differentiated from skin that is very oily.
    Generally, the inclusion criteria are composed to serve the goal of the study and the exclusion criteria to protect the panelist and/or to ensure that inappropriate population is not selected. The inclusion criteria should be broad enough to allow the CRO relatively easy recruitment and precise enough so that the relevant panelists are enrolled. It should be stressed that the population selected for the study should not be such that exhibits better odds to respond under the study conditions but rather such that reflects the population to which the product will be marketed. For example, if the product is aimed at elderly population, such population may be slower and less responsive to the treatment when compared to a younger population. Still, the age range to which the product is marketed should be reflected in the study design.


    Typical “exclusion/ inclusion” criteria refer to aspects such as: age range; ethnicity; gender; skin condition; exclusion of disease that is systemic or topical; lifestyle; drug or vitamin intake; pregnancy or maternity; ability to understand treatment regimen; study goals and product’s intended use; and consent, commitment, practical, physical and mental ability to follow the treatment protocol.


    A very important criterion that is often missed in the protocol is assurance that the panelists recruited are not already using a product that exhibits a similar effect to the tested product or a product that may affect the study results. Such a product can be a cosmetic, drug, topical, oral or other systemic. In fact, since a normal skin cell turnover is approximately 30 days ideally, study protocol should include a clause that panelists should not be using any skin care or other product that may interfere with the study results at least four weeks before the study begins, preferably even six weeks.


    Study Design


    When selecting the population for the study of interest and after the objective is clearly defined the protocol designer should ensure study is shaped to produce valid results. The validity of the study should be internal and external in nature. The purpose of internal validity is to shape the study in a manner at which the treatment applied indeed works for the defined population. For this reason, the protocol should control important variables to ensure that only the intervention of interest and no other treatment impact the outcome. For example, in a study with an objective to measure skin barrier strength by transepidermal water loss (TEWL) at which the active of interest is incorporated into an emulsion base, it is imperative that the base itself is tested as a control since it is reasonable to anticipate some effect on TEWL; as such, the results of the treatment of active can be normalized to the base as the control.


    The external validity addresses results generalization. Here, the protocol should be designed in a manner that will allow concluding from study population to the general population or marketed population of interest. A product that is aimed at women in their 50-60s should be tested on peri- or post-menopausal women of this age. If such a product is tested on a younger population its results cannot be generalized to the population of interest.


    Since it is very possible for one or two exclusion criteria to exhibit a dramatic effect on the study population, a close collaboration should be established with the clinical research facility to ensure that these criteria do not significantly limit the recruitment capabilities. Moreover, both the product manufacturer and the laboratory should remain flexible to modify the criteria if, when recruitment begins, the criteria limits significantly the panel recruited. Such modification could be either dropping the problematic parameter altogether if not critical for the study or, if critical, limit the duration to which the exclusion applies, reducing or modifying the limiting factor or imposing additional conditions to be met.


    Exclusion criteria to consider include pregnant or breast feeding; hormone therapy; inflammatory and/or allergic skin conditions chronic or relapsing such as atopic dermatitis, rosacea, psoriasis and alike including telangiectasias (“spider veins”); adult acne; history or current skin cancer; herpes infections; history of keloids; cardiac abnormalities; diabetes; facial irradiation and/or peel; extensive aesthetic procedures; unrealistic panelist expectations; significant systemic and/or inflammatory disease; HIV; significant immunosuppression; emotional instability or mental illness; and scleroderma or collagen vascular diseases.


    The inclusion criteria should be detailed to allow recruitment of desired panel. Study design may include and reference known published scales that can fully adopted or modified as needed. Examples for known scales in a skin aging study that can be adopted and/or modified for inclusion criteria may be the classification by Glogau and Fitzpatrick (see charts below).


    Glogau scale was developed by the dermatologist Richard Glogau.  It was developed to objectively measure the severity of photoaging and especially wrinkles. The Fitzpatrick scale is a numerical classification scheme for human skin color. It was developed in 1975 by Thomas B. Fitzpatrick as a way to estimate the response of different types of skin to ultraviolet (UV) light.


    In summary, the panelists selected for the study provide the foundation baseline for its success. They should be selected carefully and highly respected. The CRO conducting the study should be instructed as to the selection criteria and its meaning. Since it was not involved in the product design, it must be guided by R&D. 


     

     






























































    Nava Dayan
    Owner
    Dr. Nava Dayan LLC

    Nava Dayan Ph.D. is the owner of Dr. Nava Dayan L.L.C, a skin science and research consultancy and serving the pharmaceutical, cosmetic, and personal care industries. She has 25 years of experience in the skin care segment, and more than 150 publication credits.
    Tel: 201-206-7341
    E-mail: nava.dayan@verizon.net
    Related Searches
    • acne
    • industry
    • products
    • treatment
    Suggested For You
    Isosorbide Di-(Linoleate/Oleate) Treats Xerotic Pruritic Skin Isosorbide Di-(Linoleate/Oleate) Treats Xerotic Pruritic Skin
    International Cosmetics Science Centre Founder Honored International Cosmetics Science Centre Founder Honored
    Racial Bias in Retail Racial Bias in Retail
    Follain Supports Black-Owned Beauty Businesses Follain Supports Black-Owned Beauty Businesses
    The Next Normal The Next Normal
    Beauty Is a Bargain in the US Beauty Is a Bargain in the US
    Better by The Box Better by The Box
    Online Buying Is Here to Stay Online Buying Is Here to Stay
    Beauty Is on the Mend Beauty Is on the Mend
    Makeup Museum & L Makeup Museum & L'Oréal USA Publish Beauty Stories
    Sabinsa’s Macumax Formula Demonstrates Vision Health Benefits Sabinsa’s Macumax Formula Demonstrates Vision Health Benefits
    Skin Microbiome-based Mosquito Repellent Skin Microbiome-based Mosquito Repellent
    Protecting Skin Against Mosquito-borne Infectious Disease Protecting Skin Against Mosquito-borne Infectious Disease
    Sytheon Raises the Limit of Isosorbide Esters to the Max - From Skin Care to Brain Care Sytheon Raises the Limit of Isosorbide Esters to the Max - From Skin Care to Brain Care
    Work From Home Won Work From Home Won't Work for Everyone

    Related Claims Substantiation

    • Panelist Experience Is Critical in Clinical Study Design

      ...
      Nava Dayan, Dr. Nava Dayan LLC 05.01.18

    • Actives | Functional Ingredients | OTC/Medicated | Packaging | Skin Care | Sun Care | Testing

      Formulation Stability’s Impact on the Clinical Outcome

      ...
      Nava Dayan, Dr. Nava Dayan LLC 01.04.18

    • Actives | Color Cosmetics | Functional Ingredients | Hair Care | Personal Cleansers | Skin Care | Sun Care | Testing

      Evaluating the Efficacy of Natural Cosmetics

      ...
      Nava Dayan, Dr. Nava Dayan LLC 11.01.17


    • Skin Care | Testing

      Gender Matters in Skin Care Testing

      ...
      Nava Dayan, Dr. Nava Dayan LLC 09.01.17

    • Actives | Functional Ingredients | Preservatives | Skin Care | Testing
      Are In Vitro Results Enough To Make Product Claims?

      Are In Vitro Results Enough To Make Product Claims?

      Use the data only after considering study limitations.
      Nava Dayan, Dr. Nava Dayan LLC 07.03.17

    • Actives | Functional Ingredients | Skin Care | Sun Care

      Using Data from Studies Conducted by Suppliers

      ...
      Nava Dayan, Dr. Nava Dayan LLC 05.01.17


    • To Tell the Truth? Or Just Tell a Lie?

      To Tell the Truth? Or Just Tell a Lie?

      ...
      Nava Dayan, Dr. Nava Dayan LLC 03.01.17

    • Color Cosmetics | Hair Care | Personal Cleansers | Skin Care | Sun Care | Testing

      Why Make Claims in the First Place?

      ...
      Nava Dayan, Dr. Nava Dayan LLC 01.06.17

    Trending
    • Nu Skin Launches ‘Clean’ Formula Line
    • P&G, L'Oréal & Amorepacific Make News At CES
    • Formulating Liquid Laundry Detergents
    • Bad Habit Taps Global Brand Ambassador & Creative Director
    • Coming Clean About Clean Beauty
    Breaking News
    • Mix:Bar Launches at Target
    • Crystal Deodorant Unveils Magnesium-Enriched Sticks
    • Euromonitor Reveals Top 10 Global Consumer Trends for 2021
    • A Surge in Interest for Supplements & Vitamins
    • Gattefossé Launches Inspiration Collection
    View Breaking News >
    CURRENT ISSUE

    January 2021

    • Stepping into the Spotlight for 2021
    • The Independent Beauty Association Supports Sensible Reform
    • Essential Workers
    • A Clean Commitment
    • Deliver & Delight
    • Reusables for Consumables In the Pandemic and Beyond
    • A Rebound for Beauty
    • Beauty Brands Must Prepare for a 'Decade of the Home'
    • A Societal Shift
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Qualitas Health/iwi Raises $10 Million in Investment Round
    Aker BioMarine Expands Krill Portfolio with Novel Protein Hydrolysate
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CHF Solutions Appoints CEO
    Freehand Partners with Imperial Medial Solutions
    Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
    NovaQuest Private Equity Acquires CoreRx
    JS Bio and Etta Biotech Advancing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Marino Belotti Presents New Website
    Essence Cosmetics Expands in the U.S.
    Sigma Beauty Launches 'Brush Care' Sets at Sephora
    Happi

    Latest Breaking News From Happi

    Mix:Bar Launches at Target
    Crystal Deodorant Unveils Magnesium-Enriched Sticks
    Euromonitor Reveals Top 10 Global Consumer Trends for 2021
    Ink World

    Latest Breaking News From Ink World

    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Packaging Printing Market Worth $433.4 Billion by 2025: MarketsandMarkets
    O-I Foundation Gifts $50k to Facilitate COVID-19 Vaccine Access
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Honeywell Delivered 225 Million Masks in December
    Techtextil, Texprocess Postponed to 2022
    Super Strong Inks Survive Tough Environments
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints SVP of Operations
    DePuy Synthes Receives 510(k) FDA Clearance for VELYS Robotic-Assisted Solution
    OrthoPediatrics Expands Agent Network in Three European Countries
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login